• Explore /
  • Poster
  • / Effect of concomitant medications on treatment response and survival in non-metastatic castrate resistant prostate cancer: Secondary analysis of the SPARTAN trial.

Effect of concomitant medications on treatment response and survival in non-metastatic castrate resistant prostate cancer: Secondary analysis of the SPARTAN trial.

Abstract Poster

Authors

null

Soumyajit Roy

Rush University Medical Center, Chicago, IL

Soumyajit Roy , Fred Saad , Shawn Malone , Yilun Sun , Daniel Eidelberg Spratt , Amar Upadhyaya Kishan , Christopher J.D. Wallis , Angela Jia , Osama Mohamad , Umang Swami , Michael Ong , Neeraj Agarwal , Simon Chowdhury , Scott C. Morgan

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary Cancer—Prostate, Testicular, and Penile

Track

Genitourinary Cancer—Prostate, Testicular, and Penile

Sub Track

Prostate Cancer– Advanced/Castrate-Resistant

Citation

J Clin Oncol 42, 2024 (suppl 16; abstr 5046)

DOI

10.1200/JCO.2024.42.16_suppl.5046

Abstract #

5046

Poster Bd #

452

Abstract Disclosures

Similar Posters

First Author: Felix Y Feng

First Author: Eric Jay Small

First Author: Neeraj Agarwal

First Author: Neal D. Shore